Table 3:
Post-surgery survival by surveillance intensity in patients alive and disease free 9 months post-surgery.
| HR (95% CI) | p-value | |
|---|---|---|
| Surveillance group: 3-month | (reference) | 0.091 |
| 6-month | 1.12 (0.98, 1.29) | |
| Histology: Adenocarcinoma | (reference) | 0.991 |
| Squamous | 0.99 (0.86, 1.14) | |
| Other histology | 1.00 (0.80, 1.26) | |
| Surgery: Lobectomy | (reference) | 0.010 |
| Pneumonectomy | 0.95 (0.70, 1.30) | |
| Segmentectomy | 1.39 (0.86, 2.26) | |
| Wedge resection | 1.34 (1.12, 1.60) | |
| Any chemotherapy | 1.01 (0.86, 1.20) | 0.976 |
| Any radiation | 1.39 (1.11, 1.72) | < 0.001 |
| Age (per decade) | 1.23 (1.12, 1.36) | < 0.001 |
| Sex: Male | (reference) | 0.011 |
| Female | 0.84 (0.73, 0.96) | |
| Chronic obstructive pulmonary disease | 1.17 (1.00, 1.37) | 0.054 |
| Congestive heart failure | 1.50 (1.14, 1.97) | 0.003 |
| Coronary artery disease | 1.11 (0.94, 1.31) | 0.215 |
| Diabetes | 1.07 (0.90, 1.29) | 0.435 |
| Peripheral vascular disease | 1.37 (1.09, 1.72) | 0.007 |
| Psychiatric | 1.20 (0.95, 1.51) | 0.133 |
| Substance abuse | 1.32 (1.03, 1.70) | 0.029 |